HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users [NA]
This clinical trial update reports the completion of a study evaluating hospital visits as opportunities for prevention and engagement for H…
-
FDA approval · 2016-03-10FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) from Gilead Sciences, Inc.
-
FDA label_change · 2016-03-10FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)
The FDA approved a supplemental application for Truvada (emtricitabine/tenofovir disoproxil fumarate) from Gilead Sciences to update the pro…
-
FDA approval · 2016-03-10FDA Approved: ETRAVIRINE — Supplemental Application (Patriot Pharmaceuticals)
FDA approved a supplemental application for ETRAVIRINE submitted by Patriot Pharmaceuticals, leading to changes to the drug's labeling and/o…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Measurement of Glomerular Filtration Rate (GFR) in HIV Patients: Single-center Study Comparing the Accuracy of Estimators of GFR Versus Iohexol Plasma Clearance [Phase 4]
Phase 4 single-center trial in HIV patients comparing different estimators of glomerular filtration rate against Iohexol plasma clearance. T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: KSHV Infection in Blood Donors From Texas
A completed clinical trial evaluating Kaposi sarcoma–associated herpesvirus (KSHV) infection in Texas blood donors, with related conditions …
-
FDA label_change · 2016-03-09FDA Approved: COMPLERA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for COMPLERA (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate) submitted…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks [Phase 2]
Phase 2 trial evaluating rosuvastatin to reduce cardiovascular risk in HIV-infected individuals has completed and results were posted in 201…
-
FDA approval · 2016-03-08FDA Approved: GENVOYA — Supplemental Application (Gilead Sciences, Inc.)
FDA granted supplemental approval for GENVOYA (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide).
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Utilization of HIV Clinical Services in Rural India [Phase 3]
Phase 3 trial update examining the utilization of HIV clinical services in rural India; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects [Phase 1, Phase 2]
This update summarizes the completed Phase 1/2 trial of a dendritic cell vaccine in HIV-1 infected subjects, with results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Screening for HIV-Associated Anal Cancer
This clinical trial update indicates the study on screening for HIV-associated anal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment
This Clinical Trial Update describes the completion of a study evaluating tuberculosis screening in HIV-infected patients eligible for antir…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine [Phase 2]
This Phase 2 trial evaluated the immunogenicity and safety of the HIV-1 Tat vaccine, reporting immune responses and safety observations in i…
-
CLINICAL_TRIALS research · 2016-03-04Clinical Trial Update: Observational Study on Anti-Tat Immune Response in HIV-1-infected Asymptomatic Adult Subjects
An observational study evaluating anti-Tat immune responses in asymptomatic adults infected with HIV-1; the study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Early HIV Therapy in Patients With High CD4 Cell Counts [NA]
This update notes the completion of a clinical trial assessing early antiretroviral therapy initiation in people with high CD4 counts.
-
CLINICAL_TRIALS research · 2016-03-04Clinical Trial Update: Observational Study on Anti-Tat Immune Response in HIV-1-infected HAART-treated Adult Subjects
Observational study assessing anti-Tat immune responses in HIV-1-infected adults on HAART.
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Study to Assess the Seroprevalence of Anti-Tat Antibodies in HIV-infected Patients
This completed clinical trial evaluated how common antibodies against the HIV Tat protein are among people with HIV.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Affect Management for Early Adolescents [Phase 2]
A Phase 2 clinical trial update on affect management for early adolescents with HIV infection; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA [NA]
A prospective study evaluating the specificity of Roche's Cobas TaqScreen MPX test for detecting HBV DNA, HCV RNA, and HIV-1 RNA in plasma p…
-
FDA approval · 2016-03-01FDA Approved: ODEFSEY — Original Application (Gilead Sciences, Inc.)
FDA approved ODEFSEY, a fixed-dose combination oral antiretroviral therapy. It contains emtricitabine, rilpivirine hydrochloride, and tenofo…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: A Study to Assess Cerebrospinal Fluid INflammatory Markers After Addition of Maraviroc to MONotherapy Darunavir/Ritonavir - The CINAMMON Study [Phase 4]
The CINAMMON Phase 4 trial evaluating cerebrospinal fluid inflammatory markers after adding maraviroc to darunavir/ritonavir in HIV treatmen…
-
CLINICAL_TRIALS research · 2016-02-26Clinical Trial Update: Operational Assessment of Point-of-Care Diagnostics in Primary Healthcare Clinics
This completed study evaluated the operational feasibility and performance of point-of-care HIV diagnostics in primary healthcare clinics.
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Smoking Cessation for HIV/AIDS Patients [NA]
Completed clinical trial update on smoking-cessation in patients with HIV infection (HIV/AIDS).
-
FDA approval · 2016-02-25FDA Approved: TRUVADA — Supplemental Application (Gilead Sciences, Inc)
FDA approved a supplemental application for TRUVADA (emtricitabine and tenofovir disoproxil fumarate) submitted by Gilead Sciences, Inc.